Trial Profile
A Multicenter, Randomized, Double-blinded, Parallel, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Oct 2016
Price :
$35
*
At a glance
- Drugs Pelubiprofen (Primary)
- Indications Back pain
- Focus Therapeutic Use
- Sponsors Daewon Pharmaceutical
- 05 Mar 2015 New trial record